Burcon NutraScience Corporation News Releases

Burcon Announces Appointment of New Director

Wed, 29 Apr 2026 17:21:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the appointment of Mr. Chris Bunio to the board of directors (the "Board") of Burcon. Mr. Bunio has been active in the technology industry for nearly 30 years. Mr. Bunio is a Co-founder and the CEO of TheoryMesh, a Winnipeg, Manitoba-based company focused on...

Burcon Closes Final Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Mon, 27 Apr 2026 07:58:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the final tranche of its previously announced non-brokered private placement (see news releases of the Company dated January 2, 2026, January 9, 2026 and February 27, 2026) of convertible debentures (the "Convertible Debentures") for an aggregate...

Burcon Achieves Record Production, Expands to More than 20 Buying Customers and Evaluates Additional Capacity Expansion

Mon, 20 Apr 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced recent operational and commercial milestones demonstrating accelerating momentum in its scale-up and commercialization strategy.Over the past several weeks, the Company achieved record production, increasing average daily output by approximately 40% as compared to the calendar Q1...

Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Fri, 27 Feb 2026 16:37:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the second tranche of its previously announced non-brokered private placement (see news releases of the Company dated January 2, 2026 and January 9, 2026) of convertible debentures (the "Convertible Debentures") for an aggregate principal amount...

Burcon Announces Results of Shareholder Meeting

Fri, 20 Feb 2026 15:33:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - February 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce that all meeting matters put forth to shareholders, as voted on by shareholders, and where applicable, disinterested shareholders, were duly approved at its 2026 special meeting of shareholders (the "Meeting") held on February 20, 2026. Shareholders of the...

Burcon Announces Fiscal 2026 Third Quarter Results

Wed, 11 Feb 2026 16:07:00 -0500

Strong Q3 Revenue Growth Driven by Expanding Commercial Traction Vancouver, British Columbia--(Newsfile Corp. - February 11, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal third quarter ended December 31, 2025."Fiscal Q3 marked an important milestone in Burcon's commercial growth," said Kip Underwood, Burcon's chief executive officer. "We ramped production,...

Burcon Announces Details on Special Meeting of Shareholders and Amendment to Outstanding Warrants

Wed, 04 Feb 2026 17:53:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - February 4, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will be holding a special meeting (the "Meeting") of shareholders at 10 am Pacific Time on February 20, 2026 held virtually via live webcast at https://meetnow.global/M97FRAF.Warrant AmendmentBurcon announces that the expiry date of certain outstanding warrants of the Company...

Burcon Announces Fiscal 2026 Third Quarter Conference Call and Presentation to be Held on February 11, 2026

Wed, 28 Jan 2026 08:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 28, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, February 11, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal 2026 third quarter ended December 31, 2025. The Company's financial results will be issued in a press release prior to the...

Burcon Increases Non-Brokered Private Placement of Convertible Debentures to $6.9 Million

Fri, 09 Jan 2026 08:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 9, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce that, in response to strong demand, it has increased the size of its previously announced non-brokered private placement (the "Private Placement") of convertible debentures (the "Convertible Debentures") to an aggregate principal amount of up to $6.9 million. For...

Burcon Announces Closing of First Tranche of Non-Brokered Private Placement of Convertible Debentures

Fri, 02 Jan 2026 08:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 2, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the first tranche of a non-brokered private placement of convertible debentures (the "Convertible Debentures") for an aggregate principal amount of up to $6.3 million (the "Private Placement"). Insiders of the Company and Burcon's manufacturing...